The allograft uses Bacterin’s proprietary demineralization technology and is designed specifically for addressing multi-level spine procedures and deformity cases.
Bacterin International develops and markets biologics products to domestic and international markets.
More Articles on Device:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
